, Tracking Stock Market Picks
Enter Symbol:
Smith & Nephew Snats, Inc. (SNN) [hlAlert]

Mkt Outperform
up 45.08 %

Smith & Nephew Snats, Inc. (SNN) rated Mkt Outperform with price target $30 by Rodman & Renshaw

Posted on: Friday,  Jan 18, 2008  8:25 AM ET by Rodman & Renshaw

Rodman & Renshaw rated Mkt Outperform Smith & Nephew Snats, Inc. (NYSE: SNN) on 01/18/2008, when the stock price was
$24.45. Since then, Smith & Nephew Snats, Inc. has gained 45.08% as of 12/07/2015's recent price of $35.47.
If you would have followed this Rodman & Renshaw's recommendation on SNN, you would have gained 45.08% of your investment in 2880 days.

Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world

Rodman & Renshaw is a full-service investment bank dedicated to providing investment banking services to companies that have significant recurring capital needs due to their growth and development strategies. We also provide research and sales and trading services to institutional investor clients that focus on such companies. Since 2003, Rodman has been a leading investment banking firm to the biotechnology sector, a capital intensive market segment, as well as a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/18/2008 8:25 AM Buy
24.45 12.00
as of 12/24/2008
1 Week down  -1.56 %
1 Month up  0.29 %
3 Months up  3.64 %
1 YTD down  -47.11 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy